156 related articles for article (PubMed ID: 18483241)
1. Down-regulation of p57Kip2 induces prostate cancer in the mouse.
Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ
Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].
Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH
Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960
[TBL] [Abstract][Full Text] [Related]
3. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.
Mishra S; Lin CL; Huang TH; Bouamar H; Sun LZ
Mol Cancer; 2014 Sep; 13():212. PubMed ID: 25216674
[TBL] [Abstract][Full Text] [Related]
5. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.
Vlachos P; Joseph B
Oncogene; 2009 Nov; 28(47):4175-88. PubMed ID: 19734939
[TBL] [Abstract][Full Text] [Related]
6. The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway.
Vlachos P; Nyman U; Hajji N; Joseph B
Cell Death Differ; 2007 Aug; 14(8):1497-507. PubMed ID: 17464323
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells.
Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944
[TBL] [Abstract][Full Text] [Related]
8. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes.
Curry JL; Richards HW; Huttenbach YT; Medrano EE; Reed JA
J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205
[TBL] [Abstract][Full Text] [Related]
9. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of p57kipĀ² promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells.
Chow SE; Wang JS; Lin MR; Lee CL
J Cell Biochem; 2011 Nov; 112(11):3459-68. PubMed ID: 21769918
[TBL] [Abstract][Full Text] [Related]
11. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
12. p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues.
Fan GK; Xu F; Yang B; Fujieda S
Acta Otolaryngol; 2006 Mar; 126(3):301-5. PubMed ID: 16618659
[TBL] [Abstract][Full Text] [Related]
13. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
Taniguchi T; Okamoto K; Reeve AE
Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide expression profiling of placentas in the p57Kip2 model of pre-eclampsia.
Knox KS; Baker JC
Mol Hum Reprod; 2007 Apr; 13(4):251-63. PubMed ID: 17289831
[TBL] [Abstract][Full Text] [Related]
15. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
Figliola R; Busanello A; Vaccarello G; Maione R
J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
[TBL] [Abstract][Full Text] [Related]
16. Expression of P57(kip2) and cyslinE proteins in human pancreatic cancer.
Yue H; Yu J; Zhao X; Song F; Feng X
Chin Med J (Engl); 2003 Jun; 116(6):944-6. PubMed ID: 12877813
[TBL] [Abstract][Full Text] [Related]
17. Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues.
Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Int J Mol Med; 2002 Apr; 9(4):373-6. PubMed ID: 11891530
[TBL] [Abstract][Full Text] [Related]
18. Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14.
Hsu S; Yamamoto T; Borke J; Walsh DS; Singh B; Rao S; Takaaki K; Nah-Do N; Lapp C; Lapp D; Foster E; Bollag WB; Lewis J; Wataha J; Osaki T; Schuster G
J Pharmacol Exp Ther; 2005 Mar; 312(3):884-90. PubMed ID: 15537824
[TBL] [Abstract][Full Text] [Related]
19. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells.
Schwarze SR; Shi Y; Fu VX; Watson PA; Jarrard DF
Oncogene; 2001 Dec; 20(57):8184-92. PubMed ID: 11781834
[TBL] [Abstract][Full Text] [Related]
20. p57(Kip2) and cancer: time for a critical appraisal.
Borriello A; Caldarelli I; Bencivenga D; Criscuolo M; Cucciolla V; Tramontano A; Oliva A; Perrotta S; Della Ragione F
Mol Cancer Res; 2011 Oct; 9(10):1269-84. PubMed ID: 21816904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]